Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders

Manuscript Number: 

20-0487R1

Author(s): 
Cyrus A. Raji, Daniel H.S. Silverman, Nare Torosyan

Disclosures

Cyrus A. Raji

  • Consulting Fees:
    Brainreader ApS Apollo Health
    Patents/Royalties
    Expert Witness Role with Neurevolution LLC

Daniel H.S. Silverman

  • Consulting Fees:
    Eisai, Inc. -- Served on advisory at a single event (in conjunction with Society of Nuclear Medicine and Molecular Imaging, Mid-Winter Meeting 2020)
    Lecture Fees:
    Eisai, Inc. -- Served as speaker at a single event (satellite to Society of Nuclear Medicine and Molecular Imaging, Mid-Winter Meeting 2020)
    Patents/Royalties
    Co-inventor of algorithms utilized in NeuroQ™, licensed by University of California to Syntermed, Inc.
    Grants
    • Agency: 
      Eisai, Inc.
      Dates: 
      2018-2020

Nare Torosyan

  • Nothing to Disclose